Fluorescence and chromogenic in situ hybridization to detect genetic aberrations in formalin-fixed paraffin embedded material, including tissue microarrays.
about
Epigenomic profiling of prostate cancer identifies differentially methylated genes in TMPRSS2:ERG fusion-positive versus fusion-negative tumors.Tumour Heterogeneity: The Key Advantages of Single-Cell AnalysisFast and non-toxic in situ hybridization without blocking of repetitive sequencesProstate cancer risk regions at 8q24 and 17q24 are differentially associated with somatic TMPRSS2:ERG fusion status.Genetic amplification of the vascular endothelial growth factor (VEGF) pathway genes, including VEGFA, in human osteosarcomaOCT1 is a determinant of synbindin-related ERK signalling with independent prognostic significance in gastric cancerA meta-analysis of 87,040 individuals identifies 23 new susceptibility loci for prostate cancer.Obesity and Prostate Cancer Risk According to Tumor TMPRSS2:ERG Gene Fusion Status.Prognostic and predictive value of MET deregulation in non-small cell lung cancerImpact of fusion gene status versus histology on risk-stratification for rhabdomyosarcoma: Retrospective analyses of patients on UK trials.Improved Swiss-rolling Technique for Intestinal Tissue Preparation for Immunohistochemical and Immunofluorescent Analyses.Aspirin and NSAID use in association with molecular subtypes of prostate cancer defined by TMPRSS2:ERG fusion status.Distinct genomic alterations in prostate cancers in Chinese and Western populations suggest alternative pathways of prostate carcinogenesis.Genomic gain and over expression of CCL2 correlate with vascular invasion in stage I non-seminomatous testicular germ-cell tumours.Identification of frequent BRAF copy number gain and alterations of RAF genes in Chinese prostate cancer.
P2860
Q27323950-088B32A8-1A78-4D66-B402-D6F6BB74DB50Q28066914-89B28947-A43F-4177-92DF-EC7CDA63B829Q28728860-0BB8A1CC-3B2B-4CCA-AEC1-C0C107441EBBQ33640983-3A361F4C-7B98-489A-8D86-D09E58FE3E9CQ34628523-09AFB97B-44BD-4734-876C-25A1CE00322BQ34818674-650A3C62-7754-4819-B878-6BE2793E25F4Q35248192-DCFDF707-C699-40CE-B529-261F3997DC8EQ35535396-92218E18-B879-43A1-901A-C60B3D089603Q38493294-63BDB922-14AA-40A2-96F2-D2EB52E3EDE3Q38776314-E75CF8B7-69DB-4AE0-98F5-B7668E92A483Q39512662-0784B13E-BC2A-4531-B007-8D27721DF6E3Q41184528-5156E93C-9C5A-4EAD-9E4A-E9B46D17A8CEQ42089044-D100145F-7755-4A5C-B853-3ED7FAF825C4Q46315247-E00EDCD4-C0F2-4257-B6AF-E1E78E941D22Q54494653-914088FA-F253-4471-A201-331FE1A100D4
P2860
Fluorescence and chromogenic in situ hybridization to detect genetic aberrations in formalin-fixed paraffin embedded material, including tissue microarrays.
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
2008年论文
@zh
2008年论文
@zh-cn
name
Fluorescence and chromogenic i ...... including tissue microarrays.
@en
type
label
Fluorescence and chromogenic i ...... including tissue microarrays.
@en
prefLabel
Fluorescence and chromogenic i ...... including tissue microarrays.
@en
P2093
P2860
P356
P1433
P1476
Fluorescence and chromogenic i ...... including tissue microarrays.
@en
P2093
Brenda Summersgill
Janet Shipley
Jeremy Clark
P2860
P2888
P304
P356
10.1038/NPROT.2007.534
P577
2008-01-01T00:00:00Z
P6179
1035793554